YTK-105
CAS No. 774192-20-0
YTK-105( —— )
Catalog No. M37597 CAS No. 774192-20-0
YTK-105 is a ligand targeting autophagy that binds to p62.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 61 | In Stock |
|
| 10MG | 93 | In Stock |
|
| 25MG | 188 | In Stock |
|
| 50MG | 310 | In Stock |
|
| 100MG | 496 | In Stock |
|
| 200MG | 706 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameYTK-105
-
NoteResearch use only, not for human use.
-
Brief DescriptionYTK-105 is a ligand targeting autophagy that binds to p62.
-
DescriptionYTK-105 is a ligand targeting autophagy that binds to p62.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number774192-20-0
-
Formula Weight257.33
-
Molecular FormulaC16H19NO2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESOCCNCC=1C=CC=C(OCC=2C=CC=CC2)C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
(Pyr5,N-Me-Phe8,Sar9...
[Glp5,(Me)Phe8,Sar9] Substance P (5-11) (DiMe-C7) is a Substance P analogue that has approximately the same effects as Substance P on neurokinin 1 receptor (NK1R) in rat brain, but with a much longer duration of action. [Glp5,(Me)Phe8,Sar9] Substance P (5-11) selectively activates dopamine metabolism in the mesencephalon and midbrain cortex of the rat brain. [Glp5,(Me)Phe8,Sar9] Substance P (5-11) also increases motor activity and induces recovery of addictive agent-seeking behavior in rats.
-
(2R,3S,11bS)-Dihydro...
(2R,3S,11bS)-9,10-dimethoxy-3-(2-methylpropyl)-1H,2H,3H,4H,6H,7H,11bH-pyrido[2,1-a]isoquinolin-2-ol is an impurity of Tetrabenazine, which is a VMAT inhibitor used in the treatment of hyperkinetic movement disorder.
-
4-Methoxycoumarine
4-Methoxycoumarine has antitumour effects.Coumarin has antitumour effects in vivo and cytostatic effects in vitro. Its half-life in humans is short (1-1.5 h) and the monohydroxylated biotransformation products have significantly longer half-lives.
Cart
sales@molnova.com